A rapid method to reduce drug interferences for antibody measurements in pegunigalsidase alfa-treated patients with Fabry disease
We present a rapid alkaline-treatment based method to overcome drug interferences to measure at least free antibodies in patients treated with pegunigalsidase alfa.
Authors
- Michael A. Rudnicki (ORCID: https://orcid.org/0000-0002-3866-5249)
- Markus Cybulla (ORCID: https://orcid.org/0000-0001-7414-3096)
- Malte Lenders (ORCID: https://orcid.org/0000-0001-8409-2886)
- Eva Brand
- Elisa Rudolph
Institutions
- Innsbruck Medical University (AT)
- University Hospital Münster (DE)
- Center for Rheumatology (US)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-13
- DOI
- https://doi.org/10.3389/fimmu.2025.1724835
- Primary Topic
- Lysosomal Storage Disorders Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00